Although we demonstrated that both supplementation with a PGK inhibitor and supplementation with estradiol had protective effects on placental and pregnancy outcomes in women with GDM, whether these protective effects are dependent on the recovery of β-cell function or independent needs further investigation. Here, PRKG1 is linked to gestational diabetes.